Oragenics, Inc.
OGEN
$0.50
-$0.01-2.27%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.53M | -2.20M | -2.29M | -3.07M | -2.27M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | 0.00 | 0.00 | 578.60K |
| Total Other Non-Cash Items | 17.60K | 22.40K | 738.00K | 6.00K | 6.60K |
| Change in Net Operating Assets | 324.40K | -21.80K | -1.29M | 76.00K | 372.50K |
| Cash from Operations | -2.19M | -2.20M | -2.84M | -2.98M | -1.31M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 4.00M | -- | -- | -- |
| Cash from Investing | 0.00 | 4.00M | -- | -- | -- |
| Total Debt Issued | -- | -- | -167.50K | 394.80K | 0.00 |
| Total Debt Repaid | -56.10K | -171.20K | 0.00 | -3.00M | -133.00K |
| Issuance of Common Stock | 0.00 | 79.20K | -- | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -1.10K | -- | -- |
| Issuance of Preferred Stock | -- | -- | 0.00 | 15.02M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -56.10K | -92.00K | -168.60K | 12.41M | -133.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.24M | 1.71M | -3.00M | 9.43M | -1.45M |